Zimmer Biomet (NYSE: ZBH)
Zimmer Biomet Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Zimmer Biomet Company Info
Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. The company operates through the following segments: Americas Orthopedics, EMEA, Asia Pacific, and Americas Spine and Global Dental. The Americas Orthopedics segment consists of the U.S. market and includes other North, Central, and South American markets for the firm’s orthopedic product categories. The EMEA segment focuses on Europe and includes the Middle East and African markets for all product categories except Dental. The Asia Pacific segment consists of Japan, China, and Australia and includes other Asian and Pacific markets for all product categories except Dental. The Americas Spine and Global Dental segment focuses on the U.S. market and includes other North, Central, and South American markets for the firm's spine business, and all geographic markets for its dental business. This segment is also involved in research, development engineering, medical education, and brand management. The company was founded by Justin O. Zimmer in 1927 and is headquartered in Warsaw, IN.
News & Analysis
1 More Excellent Reason to Love This Leading Healthcare Company
As elective surgery candidates return to operating rooms, revenue will ramp up.
[TIMESENSITIVE] How Zimmer Biomet Zoomed Past Wall Street's Q3 Estimates
The company's recovery from the COVID-19 pandemic was better than expected.
As Coronavirus Cases Climb, Here's 1 Stock to Buy and 1 to Avoid
New daily records for COVID-19 cases and hospitalizations mean these stocks are probably headed in opposite directions.
3 Cheap Surgical Stocks to Buy Now Before They Bounce Back
The pandemic hit Zimmer, Smith+Nephew, and Stryker hard -- but they'll soon rise again.
Can Medical Device Stocks Help Rebuild Your Portfolio?
Some of the biggest medical device companies' stocks have dropped to attractive prices due to the current COVID-19 pandemic.
How Zimmer Biomet Holdings Beat Expectations in Q4
The company's hip and knee replacement products continue to enjoy solid demand.
3 Large-Cap Healthcare Stocks Recently Hitting All-Time Highs: Are They Buys?
Huge year-to-date gains have propelled these stocks to record highs. But can their sizzling momentum continue?
Zimmer Biomet Holdings Sales and Earnings Slip in Q1
The musculoskeletal healthcare company continues to try to turn things around, with limited success in the first quarter.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.